Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UID3 (
FFR
)
233
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Stent thrombosis is a lethal complications and most important unresolved issues of the current PCI. For stent thrombosis prophylaxis of DES implantation patient, there is not a plan of surgery within six months at least, bleeding risk is low, to select patients with good adherence, and a new generation of low-thrombosis DES when implanted select the DES, and then select the appropriate stent size, the length using IVUS, OCT, the
FFR
, and without creating a dissection at the edges in the high-pressure expansion, and perform sufficient expansion,
DAPT
after surgery is at least 12 months it is desirable, but it is necessary to consider the balance of the benefit of thrombosis prophylaxis and risk of bleeding DES implantation site, the patient, to determine drug resistance, drug combination be considered in individual cases the selection
DAPT
period, the single agent.
...
PMID:[Antiplatelet therapy after drug-eluting stent implantation]. 2516 28
